AsemconnectVietnam - Viet Nhat Medical Equipment Joint Stock Company (code JVC - HOSE floor) announced the organization of the 2022 Annual General Meeting of Shareholders, which is scheduled to be held on July 19 in Hanoi.

Accordingly, in 2022 (accounting year April 1, 2022 - March 31, 2023), JVC sets a target of VND500 billion in revenue and VND25 billion in profit after tax. It is known that in 2021, the Company recorded a profit after tax loss of VND29.97 billion, this is the second consecutive year of loss.
JVC has not completed the business plan for many years. In which, especially for 2 consecutive years, in 2020 the company loss VND76.7 billion and in 2021 the company loss VND29.97 billion. As of March 31, 2022, the total accumulated loss amounted to VND 1,121.8 billion, equal to 99.7% of charter capital.
The company is oriented to gradually transform into a trading and service company by providing comprehensive medical and health care services; completely handle the financial, debt and legal backlogs.
Regarding dividend policy, because the Company is experiencing accumulated losses, it continues to submit to shareholders a plan not to pay dividends in 2021.
In addition, Viet Nhat Medical Equipment has just said that it will stop the private placement of shares approved on December 10, 2021 at the 2021 Annual General Meeting of Shareholders for the reason of changing plans and The Company's capital needs at the present time, so the Board of Directors realizes that it is not necessary to implement the plan of private placement of shares.
Previously, at the Annual General Meeting of Shareholders in 2021, the Company planned to issue 20 million individual shares at the price of VND10,000/share to raise VND200 billion. In which, the Company plans to use VND100 billion to supplement working capital, VND50 billion to repay bank loans and VND50 billion to contribute capital to Viet Nhat Medical Technology Investment Joint Stock Company.
N.Nga
Source: VITIC/Tinnhanhchungkhoan